(Reuters) - Laboratory equipment maker Thermo Fisher Scientific Inc will buy privately held transplant diagnostics firm One Lambda for $925 million in cash to expand its fast-growing specialty diagnostics segment. One Lambda's diagnostic tests are used by transplant centers for tissue typing to determine the compatibility of donors and recipients, and for potential transplant rejection. The ...
